Vytorin - Newsfeeds

FDA Bans Import of Meds From Major Drug Maker
ABC News' Brian Hartman and Kate Barrett contributed to this report. Correction: On our World News piece, we indicated that a generic version of the drug Vytorin came from one of the two Ranbaxy plants. In fact, Vytorin, made by Merck/Schering-Plough ...
Are There Any Prescribed Medications That Increase My Risk Of Becoming Depressed (E.G., The Pill, Accutane, Steroids)?
Examples of drugs that the FDA has recently become concerned with and has added warnings to are drugs used to treat acne -- such as Acutane -- drugs used to treat high cholesterol levels -- such as Vytorin -- drugs that are used to treat inflammation and ...
The Pragmatist
As Vermont looks to replace the power from the imminent close of Vermont Yankee, it begins debates about projects to produce this power. Most notably, the Vermont Public Service Board is holding public hearings to discuss the Lowell Wind Project — an ...
Combination therapy may reduce albuminuria in patients with type 2 diabetes: Study
Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology . The published study results suggest that atrasentan ...
Widely read free medical journals hype drugs: study
The researchers, whose findings appear in the Canadian Medical Association Journal, mined several German journals for articles on a range of heavily promoted newer drugs, such as Merck's cholesterol drug Zetia. Among five free journals, there were 253 ...
Eisai announces publication of Halaven Phase III study results against breast cancer in The Lancet journal
Eisai announced today that results from the global Phase III clinical study "EMBRACE" (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus Eribulin) will be published online in The Lancet . The EMBRACE study showed that Halaven ...
Widely read free medical journals hype drugs: study
The researchers, whose findings appear in the Canadian Medical Association Journal, mined several German journals for articles on a range of heavily promoted newer drugs, such as Merck's cholesterol drug Zetia. Among five free journals, there were 253 ...
Stevens' Dr. A. K. Ganguly receives Topliss Award Lecture from University of Michigan
Many of his significant contributions are in drug discovery. He is associated with the discovery of Ezetimibe (Zetia), a cholesterol absorption inhibitor, Noxafil (Posaconazole), a potent antifungal, Boceprevir a potent antiviral agent that inhibits HCY ...
Men’s basketball captures NESCAC title
The Middlebury men’s basketball team made history last weekend. The Panthers tied the school record for most wins in a season, avenged their only loss with a victory over Williams, securing the school’s second NESCAC championship and, to top it all off ...
Local folkies play intimate show at 51 Main
Despite last Friday’s bleak weather, the performance by Vermont’s own Split Tongue Crow managed to create a warm atmosphere at 51 Main. The five-piece band played a selection of earnest songs about life and loss that entertained and impressed an ...
Widely read free medical journals hype drugs: study
The researchers, whose findings appear in the Canadian Medical Association Journal, mined several German journals for articles on a range of heavily promoted newer drugs, such as Merck's cholesterol drug Zetia. Among five free journals, there were 253 ...
FDA Urged to Lift Warnings on Long-Term Use of Nicotine Gum, Patches
The FDA is reviewing the long-term use of over-the-counter nicotine replacement products, such as gum and patches, which appear to have no side effects after extended use and have proven effective in helping people stop smoking.  Currently, nicotine gum ...
FDA clears Entellus Medical's new FinESS Endoscope
Entellus Medical, a Minnesota-based medical technology company, announced today that the U.S. Food and Drug Administration cleared the company's new FinESS Endoscope. The endoscope is used with the FinESS Sinus Treatment, which employs minimally-invasive ...
Widely read free medical journals hype drugs: study
The researchers, whose findings appear in the Canadian Medical Association Journal, mined several German journals for articles on a range of heavily promoted newer drugs, such as Merck's cholesterol drug Zetia. Among five free journals, there were 253 ...
Viewpoints: GOP's 'war' on family planning; state workers' health costs; health law already hurting U.S.
The Seattle Times : Solve Health-Care Challenge By Reducing Costs, Not Shifting More Costs To Workers Continuing to "solve" the high cost of medical benefits by cost-shifting to employees will only deter budget-minded members from seeking care during the ...
Aegerion Pharmaceuticals Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer
where she worked on the development of several cholesterol-reducing drug candidates, including the CETP inhibitor, anacetrapib, intended to treat hypercholesterolemia, and Vytorin(R). At Merck, Dr. Tribble was also a member of the Cholesterol Task Force of ...
Widely read free medical journals hype drugs: study
The researchers, whose findings appear in the Canadian Medical Association Journal, mined several German journals for articles on a range of heavily promoted newer drugs, such as Merck's cholesterol drug Zetia. Among five free journals, there were 253 ...
Unequal Protection You Can
Obamacare waivers violate the Constitution’s guarantee of equal protection. Shattering the Obamacare Death Star, however, may require slamming it from multiple directions. Hence, an additional legal strategy should address this law’s apparent violation ...
Newest Knick Carmelo Anthony gets sandwich honor at Carnegie
Carmelo Anthony will likely bring fans to the Garden. His sandwich will almost definitely bring indigestion to Carnegie Deli customers. In honor of the Knicks new forward, the famed midtown deli is unveiling a gut-busting sandwich named the Melo. The ...
Cholesterol: The good, the bad, the unknown
She also has taken Lipitor, a statin drug; Zetia, one of a new class of LDL-lowering medications; and niacin. However, unlike Williams, Ranson's levels have not improved to heart-healthy levels, and while she has not had another cardiovascular incident ...
Want to contact a District of Columbia Vytorin attorney? ...Get a free case evaluation from one of our District of Columbia Vytorin attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.


Pages: Previous   1   2   3   4   5   6   7   8   9   10   11   ...   Next

Need A Vytorin Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a District of Columbia Vytorin attorney? ...Get a free case evaluation from one of our District of Columbia Vytorin attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Vytorin Case - Submit Your Information Below

Do you need legal assistance with your Vytorin case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Vytorin Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.